Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ronald G. Van Valen"'
Autor:
J. Mark Hexham, Peter Heining, Alan Slade, Guido Junge, Candace Wang, Marc I Lorber, Ronald G. Van Valen
Publikováno v:
Textbook of Organ Transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eb6fed9d42374e13887dbdbfc30a5c4
https://doi.org/10.1002/9781118873434.ch141
https://doi.org/10.1002/9781118873434.ch141
Publikováno v:
British Journal of Pharmacology. 99:396-400
1. Allergen challenge by aerosol in sensitized guinea-pigs elicited non-specific airway hyperreactivity assessed by reactivity to i.v. histamine or acetylcholine. Airway hyperreactivity to histamine persisted for at least 48 h and was accompanied by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870c5b3f35f535956486c765772ade90
https://doi.org/10.1111/j.1476-5381.1990.tb14715.x
https://doi.org/10.1111/j.1476-5381.1990.tb14715.x
Autor:
M.K. Melden, D.A. Handley, Stefan Flury, Mark L. Lee, Ronald G. Van Valen, Robert N. Saunders
Publikováno v:
Immunopharmacology. 12:11-16
Platelet activating factor (paf) given intravenously produces systemic hypotension in the rat. Similar effects can be induced using endotoxin or heat-aggregated IgG challenges, which are thought to involve endogenous paf release. Extending this conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37affccd2d1b28e59685039fb4a63761
https://doi.org/10.1016/0162-3109(86)90046-9
https://doi.org/10.1016/0162-3109(86)90046-9
Autor:
Frances Ballard, Ronald G. Van Valen, Robert N. Saunders, D.A. Handley, James M. Jaffe, M.K. Melden, John C. Tomesch
Publikováno v:
Immunopharmacology. 13:125-132
Intravenous administration of platelet-activating factor (PAF) produces dose-dependent hypotension in several species. We have evaluated a recently developed PAF antagonist, SRI 63-441, for its ability to inhibit the hypotensive effect of PAF in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e345434aae15e43cb90e46daa0d1e32
https://doi.org/10.1016/0162-3109(87)90049-x
https://doi.org/10.1016/0162-3109(87)90049-x
Publikováno v:
Immunopharmacology. 11(3)
We have evaluated several effects of intravenous administration of synthetic platelet-activating factor (PAF) in the non-human primate Cebus apella. Parameters measured were hemoconcentration (monitored by changes in hematocrit), thrombocytopenia (pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299f341fe054275c7785b3a515b64b17
https://pubmed.ncbi.nlm.nih.gov/3733419
https://pubmed.ncbi.nlm.nih.gov/3733419
Publikováno v:
Proceedings, annual meeting, Electron Microscopy Society of America. 43:572-573
A wide variety of experimental models are used to develop atherosclerosis in animals. Many researchers have applied the basic premise that repetitive injury to the vascular endothelium (i.e. chemical, immunological, metabolic or physical) can induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f308b58892abd6e83f6aa89f4b699cbc
https://doi.org/10.1017/s0424820100119648
https://doi.org/10.1017/s0424820100119648
Publikováno v:
Proceedings, annual meeting, Electron Microscopy Society of America. 43:684-685
Platelet-activating factor (PAF) is a potent mediator of immune anaphylaxis. In a dose-dependent manner, PAF can induce such effects as thrombocytopenia, neutropenia, hypotension, bronchoconstriction, hemoconcentration, and negative inotropic cardiac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09718775b0548d2c860f060aab809486
https://doi.org/10.1017/s0424820100120114
https://doi.org/10.1017/s0424820100120114